AlphAIAlphAI — Financial news for AI agents
yahoo.comSEP 12 min read$SLQT

SelectQuote’s (SLQT) Cash Flow Pitch Comes With A Shrinking Top Line

SelectQuote (SLQT) reported fiscal 2026 revenue of $1.62B, up 6% YoY, with operating cash flow increasing $44M. However, it posted a Q4 net loss of $16.8M and guided fiscal 2027 revenue lower. Healthcare Services revenue grew 14% to $845M, despite drug pricing changes. The company identified $30M in annual savings from AI tools. Guidance expects fiscal 2027 revenue to decline 14% at the midpoint, with Medicare Advantage policies projected to fall further.

Original reporting
yahoo.com
Published Sep 1, 2026, 2:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 1, 2026, 2:36 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
SelectQuote’s (SLQT) Cash Flow Pitch Comes With A Shrinking Top Line — source image
Source · yahoo.com
Decision brief

The 30-second read

$SLQTBearishMed
01

Why it matters

The earnings miss and guidance cut could trigger a sell‑off, though cost‑saving initiatives may offer upside if realized.

02

Market read

Earnings and guidance update for a mid‑cap insurer with material revenue, likely to move the stock.

03

What to watch

Debt load of $800M and 12% funding cost may constrain cash flow despite operational improvements.

Relevance 8/10Novelty 8/10Timing: post‑earnings release

Background

SelectQuote shifted its narrative to cash generation, but guidance signals a top‑line decline amid regulatory pressure.

Company-level read

Ticker impact

$SLQTBearishHigh confidence
Context

SelectQuote reported FY2026 revenue of $1.62B and FY2027 revenue guidance down 14% to $1.35‑$1.45B, plus a Q4 loss, indicating weaker top‑line outlook.

Expected impact

Potential short‑term decline of 5‑10% as investors re‑price the weaker outlook.

Evidence & confidence

Guidance cut of double‑digit magnitude on a $1.6B revenue base is material and fresh, likely prompting sell pressure.

Market effects

Sector

Healthcare services and senior insurance segments may face margin pressure, affecting peers.

Regional

U.S. insurers and related fintechs could see valuation adjustments.

Global

Limited to U.S. market; no broader macro impact.

Counterpoint

What could challenge this read

If the AI‑enabled cost savings and improved pharmacy margins materialize, the stock could rebound.

Key entities

  • Company
    SelectQuote

    Insurance and healthcare services platform (NASDAQ:SLQT).

Read at source← All news

Related articles

SEP 1
$SLQTHighAI 8/10

SelectQuote (SLQT) Q4 2026 Earnings Call Transcript

SelectQuote reported fiscal 2026 revenue of $1.6B, up 6% YoY, with adjusted EBITDA of $109.1M. Healthcare Services revenue grew 14% to $845M. Fiscal 2027 guidance includes revenue of $1.35B-$1.45B and adjusted EBITDA of $90M-$115M. Management highlighted cash flow improvement and debt reduction strategies, noting industry volatility in Medicare Advantage.

aol.com3 min
AUG 25
$SLQTMedAI 8/10

SelectQuote Q4 Earnings Call Highlights

SelectQuote (SLQT) reported Q4 Healthcare Services membership at 109,000, with expected revenue decline of 10-15% in fiscal 2027 due to the Inflation Reduction Act. Senior segment revenue fell 4% to $576M but maintained 26% EBITDA margins. Life insurance revenue rose 8% to $186M. The company guided fiscal 2027 revenue at $1.35B-$1.45B and adjusted EBITDA at $90M-$115M, with cash flow doubling.

yahoo.com2 min
AUG 25
$SLQTHighAI 8/10

SelectQuote Shares Slide After Q4 Revenue Miss and Weak Fiscal 2027 Outlook

SelectQuote (SLQT) shares fell 14.69% in pre-market trading after reporting Q4 fiscal 2026 revenue of $321.7M, missing estimates, and issuing a fiscal 2027 revenue outlook of $1.35B-$1.45B, below consensus. The company reported a net loss of $16.8M, though adjusted EBITDA improved. CEO Tim Danker highlighted success in the Senior Medicare Advantage segment.

yahoo.com3 min
AUG 25
$SLQTHighAI 8/10

Why is Selectquote stock sliding today?

Selectquote (SLQT) shares dropped 16.59% in pre-market trading to $0.643 after missing Q4 2026 earnings and revenue estimates. The company reported a loss of $0.19 per share and $321.7M in revenue, while FY2027 guidance of $1.35B-$1.45B fell below consensus. Analysts had already lowered ratings due to sector headwinds, including Medicare Advantage marketing cuts and reimbursement pressures.

investing.com2 min
AUG 25
$SLQTHigh

SelectQuote, Inc. (SLQT): Results of Operations and Financial Condition

SelectQuote, Inc. (SLQT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 SelectQuote, Inc. Reports Fourth Quarter of Fiscal Year 2026 Results Fourth Quarter of Fiscal Year 2026 – Consolidated Earnings Highlights • Revenue of $321.7 million • Net loss of $(16.8) million • Adjusted EBITDA* of $11.9 million Fiscal Year 2027 Guidance Ranges:

SEC EDGAR 8-K2 min
SEP 17
$MRKMedAI 8/10

This Dividend Stock Is Beating the Market in 2026 and Yields 2.36%

Merck reported Q2 2026 revenue of $16.6B (+5% YOY) but a GAAP net loss of $1.34B due to acquisition-related charges. Adjusted EPS fell to -$0.13 from $2.13. Merck raised its 2026 sales forecast to $66.3B-$67.3B but cut adjusted EPS guidance to $2.66-$2.76. Analysts expect Q3 2026 EPS of $2.27, down 12% YOY. HSBC and Leerink raised price targets to $172 and $161, respectively. Merck's dividend yield is 2.36%.

yahoo.com3 min